Providing Tamiflu and educating on sanitizer use helped to stop spread of H1N1 at boys' summer camp

UAB study author, preeminent flu researcher, volunteered as the camp-s doctor

Providing preventive Tamiflu and educating and emphasizing the need for repeated hand sanitizer use and disinfectant spray helped stop the spread of H1N1 influenza at a boys' summer camp in northern Alabama, according the co-director of the University of Alabama at Birmingham (UAB) Division of Pediatric Infectious Diseases.

David Kimberlin, M.D., a preeminent influenza physician and researcher, volunteered as the camp's doctor in 2009 when three campers were confirmed to have H1N1. Kimberlin serves on the American Academy of Pediatrics Committee on Infectious Diseases, and he advises the federal panel that recently updated the guidelines for childhood and teen immunizations to include H1N1 vaccine.

He is the lead author on a case study of the camp outbreak published online Feb. 1 in the Archives of Pediatrics & Adolescent Medicine. It describes the targeted preventive measures undertaken by Kimberlin and the medical team, dozens of counselors and camp staff to contain the virus among campers ages 8-14 during a two-week period.

The camp session occurred in July before the H1N1 vaccine was widely available and flu infections in communal settings like camps and elder-care homes were a major concern. Kimberlin said the preventive measures undertaken at the Alabama camp were successful once the three flu-sickened campers were isolated, treated and sent home to recover. The remaining 171 campers, including Kimberlin's 10-year-old son, did not acquire flu at the camp.

The preventive measures included prescribing and giving a 10-day Tamiflu course to all campers staying in the cabins adjoining the sick campers, including all counselors and camp staff, and closely monitoring their symptoms. Also, alcohol-based hand sanitizer was provided at each of the daily activities, in the boys' cabins and in the dinning hall, and counselors were educated by the camp medical staff on the spread of flu and proper hand hygiene.

"The bottom line is prevention worked," Kimberlin said. "This was not a highly scientific study, and we never envisioned this camp to be a test-case scenario, but a targeted, antiviral prophylaxis plan activated along with strict hand sanitization and surface decontamination helped contain this disease.

"Here we have a real-world example of how planning, prevention, coordination and public-health common sense prevailed, and these kids have a great experience to look back on."

Since spring 2009, millions of Americans have been infected with H1N1 and thousands have died, including children. In most cases Tamiflu and other antivirals help control the spread of the virus, along with frequent use of hand sanitizer and disinfectant. Other actions people should take to avoiding catching and spreading flu include covering the nose and mouth with a tissue during a cough or sneeze and throwing the tissue in the trash after use or coving coughs with the bend of an elbow.

Kimberlin said in the case of the Alabama boys' camp, a targeted approach to antiviral use in those at highest risk achieved the benefits of prevention while minimizing side-effects and reducing the chance the virus would become resistant to the drug. A majority of the 65 staff and counselors and a smaller percentage of campers experienced some antiviral-related discomfort including nausea, vomiting and headaches. None of those symptoms led anyone at the camp to stop taking antiviral treatments.

Source: University of Alabama at Birmingham

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine shows potential in preventing recurrence of triple-negative breast cancer